Laura J. Havrilesky

Duke University — United States

Medicine · Health Sciences

58h-index12.7kcitations608works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(199), Endometrial and Cervical Cancer Treatments(177), Uterine Myomas and Treatments(58), Health Systems, Economic Evaluations, Quality of Life(50), Economic and Financial Impacts of Cancer(47)

Publications608 total

Corrigendum to “A review of relative dose intensity and survival in patients with metastatic solid tumors” [Crit. Rev. Oncol. Hematol. 93 (2015) 203–210]
Critical Reviews in Oncology/Hematology·2026
Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer
Cancer Medicine·2026Open Access
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer
International Journal of Gynecological Cancer·2025
Preferences of BRCA mutation carriers for attributes of risk‐reducing surgical options for breast and ovarian cancer
Cancer·2025
Cost-effectiveness of biomarker-based and universal strategies for the treatment of advanced-stage endometrial cancer
Gynecologic Oncology·2025· 1 cited
Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistribution
Gynecologic Oncology·2025
Performance of ultrasound and rates of guideline-concordant care in a diverse postmenopausal bleeding cohort
American Journal of Obstetrics and Gynecology·2025· 2 cited
Cohort effects of changes in premenopausal hysterectomy on subsequent uterine cancer incidence
Gynecologic Oncology·2025
Supply outpacing demand: Trends and geographic distribution of gynecologic oncology fellowship programs
Gynecologic Oncology·2025
(ENCORE) Surgical de-escalation within gynecologic oncology
Gynecologic Oncology·2025
Enrollment proportions and temporal trends in gynecologic oncology phase III registration clinical trials: A decade of disparities in review
Gynecologic Oncology·2025
Timely endometrial sampling after transvaginal ultrasound: Multi-institutional performance of ultrasound in menopausal bleeding assessment (PUMBA) study
Gynecologic Oncology·2025
Preferences of BRCA mutation carriers for attributes of risk-reducing surgical options for breast and ovarian cancer
Gynecologic Oncology·2025
Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer
JAMA Oncology·2025· 6 citedOpen Access
Relationship between abnormal p53 expression and high-risk histology in endometrial cancers and living in proximity to hog concentrated animal feeding operations in North Carolina
Gynecologic Oncology Reports·2025Open Access
Supplemental Table 3 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
2025Open Access
Supplemental Table 6 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
2025Open Access
Supplemental Table 9 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
2025Open Access
Supplemental Table 2 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
2025Open Access
Data from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
2025Open Access
page 1 of 31Next →

Frequent Co-authors

Angeles Alvarez Secord(21), Andrew Berchuck(16), David M. O’Malley(12), Evan R. Myers(10), Paola A. Gehrig(10), William J. Lowery(7), Amanda N. Fader(6), Daniel L. Clarke‐Pearson(6), Patricia G. Moorman(5), Jennifer M. Gierisch(5), Gillian D Sanders(5), Brian Calingaert(5), John T. Soper(5), Vic Hasselblad(5), Ronald D. Alvarez(5), Gloria Broadwater(5), Remy R Coeytaux(4), Rachel Peragallo Urrutia(4), Michaela A. Dinan(4), Amanda J McBroom(4)